Literature DB >> 23118603

Seizures in Alzheimer disease: clinical and epidemiological data.

Dionysios Pandis1, Nikolaos Scarmeas.   

Abstract

Alzheimer disease (AD) and epilepsy are disorders commonly seen in the elderly. Many studies have shown that patients with AD are at increased risk for developing seizures and epilepsy. Whereas, patients with specific types of epilepsy, such as temporal lobe epilepsy (TLE), experience some degree of cognitive dysfunction, questions have been raised as to whether these disorders share some underlying pathophysiologic mechanisms or whether one is an epiphenomenon of the other. In this report, we review some of the available clinical and epidemiologic literature on various aspects of the topic of seizures in AD, including seizure rates and types, risk factors for seizures, electroencephalographic findings, treatment options, limitations, and methodological issues. Overall, multiple aspects of the literature on seizures and epilepsy in AD, including diagnosis, risk factors, the role of EEG in diagnosis, and the response to treatment are not clear and suffer from many methodological limitations and gaps.

Entities:  

Year:  2012        PMID: 23118603      PMCID: PMC3482722          DOI: 10.5698/1535-7511-12.5.184

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN: 1535-7511            Impact factor:   7.500


  45 in total

1.  Morbus Alzheimer and morbus Pick; a genetic, clinical and patho-anatomical study.

Authors:  T SJOGREN; H SJOGREN; A G LINDGREN
Journal:  Acta Psychiatr Neurol Scand Suppl       Date:  1952

2.  Prevalence and clinical significance of epileptiform EEG discharges in a large memory clinic cohort.

Authors:  Maarten Liedorp; Cornelis J Stam; Wiesje M van der Flier; Yolande A L Pijnenburg; Philip Scheltens
Journal:  Dement Geriatr Cogn Disord       Date:  2010-05-26       Impact factor: 2.959

3.  Seizures in Alzheimer's disease: a retrospective study of a cohort of outpatients.

Authors:  Silvia Bernardi; Nicola Scaldaferri; Nicola Vanacore; Alessandro Trebbastoni; Ada Francia; Aurelio D'Amico; Massimiliano Prencipe
Journal:  Epileptic Disord       Date:  2010-02-22       Impact factor: 1.819

4.  Transient epileptic amnesia in dementia: a treatable unrecognized cause of episodic amnestic wandering.

Authors:  A L Rabinowicz; S E Starkstein; R C Leiguarda; A E Coleman
Journal:  Alzheimer Dis Assoc Disord       Date:  2000 Oct-Dec       Impact factor: 2.703

5.  EEG abnormalities are associated with different cognitive profiles in Alzheimer's disease.

Authors:  Lieke L Smits; Maarten Liedorp; Teddy Koene; Ilona E W Roos-Reuling; Afina W Lemstra; Philip Scheltens; Cornelis J Stam; Wiesje M van der Flier
Journal:  Dement Geriatr Cogn Disord       Date:  2010-11-27       Impact factor: 2.959

Review 6.  Benzodiazepine self-administration in humans and laboratory animals--implications for problems of long-term use and abuse.

Authors:  R R Griffiths; E M Weerts
Journal:  Psychopharmacology (Berl)       Date:  1997-11       Impact factor: 4.530

7.  Epilepsy: accuracy of patient seizure counts.

Authors:  Christian Hoppe; Annkathrin Poepel; Christian E Elger
Journal:  Arch Neurol       Date:  2007-11

8.  A randomized, double-blind, placebo-controlled trial of donepezil to improve memory in epilepsy.

Authors:  Marla J Hamberger; Christina A Palmese; Nikolaos Scarmeas; David Weintraub; Hyunmi Choi; Lawrence J Hirsch
Journal:  Epilepsia       Date:  2007-05-01       Impact factor: 5.864

9.  Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures.

Authors:  R H Mattson; J A Cramer; J F Collins; D B Smith; A V Delgado-Escueta; T R Browne; P D Williamson; D M Treiman; J O McNamara; C B McCutchen
Journal:  N Engl J Med       Date:  1985-07-18       Impact factor: 91.245

10.  Resting state cortical electroencephalographic rhythms are related to gray matter volume in subjects with mild cognitive impairment and Alzheimer's disease.

Authors:  Claudio Babiloni; Filippo Carducci; Roberta Lizio; Fabrizio Vecchio; Annalisa Baglieri; Silvia Bernardini; Enrica Cavedo; Alessandro Bozzao; Carla Buttinelli; Fabrizio Esposito; Franco Giubilei; Antonio Guizzaro; Silvia Marino; Patrizia Montella; Carlo C Quattrocchi; Alberto Redolfi; Andrea Soricelli; Gioacchino Tedeschi; Raffaele Ferri; Giancarlo Rossi-Fedele; Francesca Ursini; Federica Scrascia; Fabrizio Vernieri; Torleif Jan Pedersen; Hans-Goran Hardemark; Paolo M Rossini; Giovanni B Frisoni
Journal:  Hum Brain Mapp       Date:  2012-02-14       Impact factor: 5.038

View more
  33 in total

1.  Sharp Wave Ripples in Alzheimer's Disease: In Search of Mechanisms.

Authors:  Alberto Sanchez-Aguilera; Juan P Quintanilla
Journal:  J Neurosci       Date:  2021-02-17       Impact factor: 6.167

2.  Altered glutamate clearance in ascorbate deficient mice increases seizure susceptibility and contributes to cognitive impairment in APP/PSEN1 mice.

Authors:  Deborah J Mi; Shilpy Dixit; Timothy A Warner; John A Kennard; Daniel A Scharf; Eric S Kessler; Lisa M Moore; David C Consoli; Corey W Bown; Angeline J Eugene; Jing-Qiong Kang; Fiona E Harrison
Journal:  Neurobiol Aging       Date:  2018-08-07       Impact factor: 4.673

3.  Low brain ascorbic acid increases susceptibility to seizures in mouse models of decreased brain ascorbic acid transport and Alzheimer's disease.

Authors:  Timothy A Warner; Jing-Qiong Kang; John A Kennard; Fiona E Harrison
Journal:  Epilepsy Res       Date:  2014-11-26       Impact factor: 3.045

4.  Predictors of Life Expectancy in Autopsy-Confirmed Alzheimer's Disease.

Authors:  Jeff Schaffert; Christian LoBue; Linda S Hynan; John Hart; Heidi Rossetti; Anne R Carlew; Laura Lacritz; Charles L White; C Munro Cullum
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.472

Review 5.  Ketogenic diets and pain.

Authors:  Susan A Masino; David N Ruskin
Journal:  J Child Neurol       Date:  2013-05-16       Impact factor: 1.987

Review 6.  Voltage-Gated Sodium Channel β Subunits and Their Related Diseases.

Authors:  Alexandra A Bouza; Lori L Isom
Journal:  Handb Exp Pharmacol       Date:  2018

7.  Dynamic changes in murine forebrain miR-211 expression associate with cholinergic imbalances and epileptiform activity.

Authors:  Uriya Bekenstein; Nibha Mishra; Dan Z Milikovsky; Geula Hanin; Daniel Zelig; Liron Sheintuch; Amit Berson; David S Greenberg; Alon Friedman; Hermona Soreq
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-05       Impact factor: 11.205

8.  Treatment of epilepsy for people with Alzheimer's disease.

Authors:  Jia Liu; Lu-Ning Wang
Journal:  Cochrane Database Syst Rev       Date:  2021-05-11

9.  Effects of altered tau expression on dentate granule cell excitability in mice.

Authors:  Ryan A Cloyd; John Koren; Jose F Abisambra; Bret N Smith
Journal:  Exp Neurol       Date:  2021-05-21       Impact factor: 5.620

10.  Treatment of epilepsy for people with Alzheimer's disease.

Authors:  Jia Liu; Lu-Ning Wang; Li-Yong Wu; Yu-Ping Wang
Journal:  Cochrane Database Syst Rev       Date:  2018-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.